Irritants - CS, CN, CNC, CA, CR, CNB, PS Clinical Presentation

  • Author: Paul P Rega, MD, FACEP; Chief Editor: Robert G Darling, MD, FACEP   more...
 
Updated: Aug 29, 2011
 

History

  • Most pulmonary irritant exposures are self-limited. Onset of symptoms occurs in seconds to several minutes. Duration is 15-30 minutes after clothing is removed and the patient is in an open space. Reconsider the diagnosis of riot control agents if symptoms persist longer than 30 minutes. However, in one recent study, the majority of subjects who were directly sprayed with tear gas (CS) in the face still had respiratory and oral symptoms after 1 hour.[3]
  • Typically, the eyes, nose, mouth, and even airway feel a burning sensation.
  • The eye is the most sensitive organ involved and is the most immediate and severely affected of all the target organs.
    • Ocular pain, tearing, and severe blepharospasm are common. At high concentrations, chloroacetophenone (CN) is known to cause corneal epithelial damage and chemosis.
    • Conjunctival injection and periorbital edema may be noted.
    • More serious and even permanent eye injuries (eg, corneal abrasions, foreign bodies) can occur. Tear gas particles, other foreign particles, or the blast injury itself causes these injuries.
    • Patients may complain of blindness because of the intense tearing and blepharospasm, but patients who can physically open their eyes have no significant change in visual acuity.
    • Nausea, vomiting, and diarrhea may also occur.
  • Rhinorrhea, sneezing, and hypersalivation often occur as agents come in contact with sensitive mucous membranes.
  • Patients also may report cough, chest tightness, dyspnea, and wheezing, but pulmonary function test results typically are not changed. These agents can exacerbate a chronic pulmonary condition such as asthma or chronic obstructive pulmonary disease.
  • Cardiovascular function may demonstrate an increased blood pressure and heart rate, but this effect is believed to be most likely a psychological response to the situations in which tear gases typically are used.
  • Exercise exacerbates symptoms.
  • Patients develop tolerance to tear gas symptoms with chronic low-grade exposures.
  • Psychological effects (eg, anxiety) also provoke increased response.
  • Once the skin comes in contact with a riot control agent, erythema, tingling, and burning occur. Blistering may also occur after exposure to higher concentrations. These symptoms occur within minutes of exposure and last up to 1 hour after termination of exposure.
    • More severe skin injuries can occur in hot, humid environments with heavily sweating or wet patients or with prolonged or close-range exposures.
    • Patients can develop first- or second-degree burns, and delayed allergic contact dermatitis may be seen especially with exposure to CN and CS.
    • Police and by-standers may be unintended victims of riot control agents. In one study by Watson et al, 6 police officers and 1 bystander developed contact dermatitis, leukoderma, exacerbation of seborrheic dermatitis, and aggravation of rosacea following exposure to CS.[4]
  • Serious effects including death have been reported. CN has accounted for 5 deaths due to pulmonary injury and/or asphyxia. A case report involved a 4-week-old infant who accidentally received a discharge of pepper spray (OC), which immediately led to respiratory distress, followed by apnea. The infant was resuscitated and ultimately recovered after much intensive care, including extracorporeal membrane oxygenation (ECMO).[5]
    • Usually such effects (eg, pulmonary edema, chemical pneumonitis) only occur with the combination of prolonged exposure and use in an enclosed space.
    • Such exposures can damage the respiratory tree. Upper airway mucosal necrosis and pulmonary edema have been reported.
    • Some studies have suggested that CS may be converted into cyanide in the peripheral tissues. However, the risk of cyanide toxicity seems to be minimal.[6]
    • One animal study has demonstrated no adverse effects of CS during pregnancy.[6]
  • Unintentional oral ingestions can occur, specifically in children.
    • Abdominal cramps and diarrhea are common, but the ultimate course usually is uneventful.
    • The lethal dose in one half of the exposed population (LD50) in animals is 200 mg/kg, which is an amount unlikely to be ingested.
  • Other gases irritating to the mucous membranes and respiratory system (eg, lewisite, phosgene oxime) may be confused with pulmonary irritants.
    • A history of gas exposure in use by law enforcement or military training suggests tear gas use.
    • Eye symptoms are especially prominent in pulmonary irritant use.
    • Significant respiratory findings are rare but may occur in high concentrations in an enclosed space, especially in pediatric and geriatric victims with preexisting comorbidities.
Next

Physical

Physical findings of irritants are as follows[7] :

  • Respiratory signs and symptoms may include the following manifestations: cough, chest tightness, sensation of suffocation, shortness of breath, tachycardia, increased respiratory rate, wheezing, rales, decrease in oxygen saturation, cyanosis, pulmonary edema, and respiratory arrest in young infants.
  • Tachycardia, hypertension
  • Skin and mucous membranes will display the following findings: erythema, pain, blistering of the skin, first (possibly second) degree burns of the skin.
  • Eyes may display the following findings: conjunctival injection, redness, and irritation; corneal burns; pain; tearing; and blurry vision.
  • Oropharynx may display the following findings: oral burns and irritation, sore throat, hoarseness, dysphagia, and hypersalivation.
  • Nose may display the following findings: rhinorrhea, burning, irritation, and sneezing.

Severity of manifestations is dependent upon age of the victim, comorbid factors, and duration of exposure.

Previous
Next

Causes

  • Crowd control adjunct: One study appreciates the fact that law enforcement officers, as well as others, may be subjected to the effects of these irritants in the process of controlling a crowd or stemming a riot. The researchers discovered that diphoterene can be used as prophylaxis or as a decontamination agent in the event of a CS exposure.[8]
  • For more information, see the article Personal protective device.
Previous
 
 
Contributor Information and Disclosures
Author

Paul P Rega, MD, FACEP  Assistant Professor, Department of Public Health and Preventive Medicine, The University of Toledo College of Medicine; Assistant Professor, Department of Emergency Medicine, The University of Toledo College of Medicine; Director of Emergency Medicine Education and Disaster Management, OMNI Health Services

Paul P Rega, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Mark Keim, MD  Senior Science Advisor, Office of the Director, National Center for Environmental Health, Centers for Disease Control and Prevention

Mark Keim, MD is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Robert G Darling, MD, FACEP  Adjunct Clinical Assistant Professor of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine; Associate Director, Center for Disaster and Humanitarian Assistance Medicine

Robert G Darling, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, American Telemedicine Association, and Association of Military Surgeons of the US

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors, Eric Mowatt-Larssen, MD, and David P Sole, DO, to the development and writing of this article.

References
  1. Hankin SM, Ramsay CN. Investigation of accidental secondary exposure to CS agent. Clin Toxicol (Phila). May 2007;45(4):409-11. [Medline].

  2. Brone B, Peeters PJ, Marrannes R, et al. Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor. Toxicol Appl Pharmacol. Sep 2008;231(2):150-6. [Medline].

  3. Karagama YG, Newton JR, Newbegin CJ. Short-term and long-term physical effects of exposure to CS spray. J R Soc Med. Apr 2003;96(4):172-4. [Medline].

  4. Watson K, Rycroft R. Unintended cutaneous reactions to CS spray. Contact Dermatitis. Jul 2005;53(1):9-13. [Medline].

  5. Billmire DF, Vinocur C, Ginda M, Robinson NB, Panitch H, Friss H. Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenation. Pediatrics. Nov 1996;98(5):961-3. [Medline].

  6. Sam Shen. Riot-control agent attack. In: Ciottone GR, Anderson PD, Auf Der Heide E, Darling RG, Jacoby I, Noji E, Suner S, eds. Disaster Medicine. 3rd ed. Philadelphia, PA: Mosby/Elsevier; 2006:Chap 98, 593-595.

  7. Centers for Disease Control and Prevention. Riot Control Agent Poisoning. CDC: Emergency Preparedness and Response. Available at http://emergency.cdc.gov/agent/riotcontrol/agentpoisoning.asp. Accessed March 7, 2009.

  8. Viala B, Blomet J, Mathieu L, Hall AH. Prevention of CS "tear gas" eye and skin effects and active decontamination with Diphoterine: preliminary studies in 5 French Gendarmes. J Emerg Med. Jul 2005;29(1):5-8. [Medline].

  9. Army, Marine Corps, Navy, Air Force. Military Chemical Compounds and Their Properties in Potential Military Chemical/Biological Agents and Compounds. January 2005. Available at www.mipt.org/pdf/Potential-Military-Chemical-Biological-Agents-Compounds.pdf. Accessed April 2, 2005.

  10. Bentur Y, Gomez J. Incapacitating agents: BZ, calmative agents, and riot control agents. In: Keyes DC, Burstein JL, Schwartz RB, et al, eds. Medical Response to Terrorism, Preparedness and Clinical Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

  11. Blain PG. Tear gases and irritant incapacitants. 1-chloroacetophenone, 2-chlorobenzylidene malononitrile and dibenz[b,f]-1,4-oxazepine. Toxicol Rev. 2003;22(2):103-10. [Medline].

  12. CDC. Brief report: exposure to tear gas from a theft-deterrent device on a safe--Wisconsin, December 2003. MMWR Morb Mortal Wkly Rep. Mar 5 2004;53(8):176-7. [Medline].

  13. CDC. Riot Control Agent Poisoning. Centers for Disease Control and Prevention Web site. Available at www.bt.cdc.gov/agent/riotcontrol/agentpoisoning.asp. Accessed May 12, 2004.

  14. Chemical Casualty Care Division USAMRICD. Medical Response to Chemical Warfare and Terrorism. 3rd ed. i-iv, 73-79.

  15. Compton JA. Tear agents. In: Military Chemical and Biological Agents. 1987:208-252.

  16. Field Manual. Riot Control Agents. Treatment of Chemical Agent Casualties and Convention Military Chemical Injuries. Medical NBC Online Web site. Available at www.nbc-med.org/SiteContent/MedRef/OnlineRef/FieldManuals/fm8_285/Part_2/chapter7.htm. Accessed April 2, 2005.

  17. Lillie SH, Hanlon E, Kelly JM, eds. Potential Military Chemical/Biological Agents and Compounds (FM3-11.9). 2005.

  18. Nelson LS. Simple asphyxiants and pulmonary irritants. In: Goldfrank LR, Flomenbau NE, Lewin NA, eds. Goldfrank's Toxicologic Emergencies. Appleton & Lange; 1998:1523-1538.

  19. Sidell FR. Riot control agents. In: Textbook of Military Medicine. Part 1. 1997:307-324.

  20. USAMRICD. Riot Control Agents in Medical Management of Chemical Casualties Handbook. 3rd ed. USAMRICD. Available at: https://ccc.apgea.army.mil/sarea/products/handbooks/MMCC/mmccthirdeditionjul2000.pdf. July 2000.

  21. Weir E. The health impact of crowd-control agents. CMAJ. Jun 26 2001;164(13):1889-90. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.